|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2010-06-11 Purchase |
2010-06-14 3:43 pm | GeoVax Labs, Inc. | GOVX.OB | NEWMAN MARK J (VP, Research & Development) | 3,000 | $3.297 | $9,890 | 3,000 (Direct) | View |
| Transaction & Date |
Reported Date |
Exercisable Expiration |
Company | Symbol | Insider Relationship | Shares Traded |
Conversion Price |
Shares Ownership |
Filing |
| 2005-01-21 Option Award |
2005-01-21 6:17 pm | 2005-01-21 2015-01-20 |
EPIMMUNE INC | EPMN | NEWMAN MARK J (Vice President, R&D) | 20,000 | $1.47 | 20,000 (Direct) |
View |
| 2004-06-15 Option Award | 2004-06-16 3:11 pm |
2004-06-15 2014-06-14 | EPIMMUNE INC | EPMN | NEWMAN MARK J (VP Research & Development) | 20,000 | $1.92 | 20,000 (Direct) | View |
| 2004-06-15 Option Award | 2004-06-16 3:11 pm | 2004-06-15 2013-12-25 | EPIMMUNE INC | EPMN | NEWMAN MARK J (VP Research & Development) | 80,000 | $1.53 | 80,000 (Direct) |
View |
| 2003-11-07 Option Award |
2003-11-10 6:18 pm | 2003-11-08 2013-11-08 |
EPIMMUNE INC | EPMN | NEWMAN MARK J (Vice President, R&D) | 15,000 | $2.11 | 15,000 (Direct) | View |
| 2003-09-08 Option Award | 2003-09-09 8:18 pm |
2003-09-09 2013-09-08 | EPIMMUNE INC | EPMN | NEWMAN MARK J (V.P., Infectious Disease Prog.) | 35,000 | $1.54 | 35,000 (Direct) | View |
|
© 2005-2010 SecForm4.Com All rights reserved. Archives: 2010 2009 2008 2007 2006 2005 ... Thu, 29 Jul 2010 15:51:10 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |